Illumina, HLA-HS-1005-24, oncoReveal Fusion LBx 24 Rxn
18 gene (24 sample) liquid biopsy cfRNA panel on SLIMamp™ workflow
Catalog Number: HLA-HS-1005-24
Send an RFQ.
Category
Pack Size24 reactions
| Assay time | 48 hr from sample to report |
|---|---|
| Hands-on time | ~3 hr |
| Input quantity | 10–30 ng cfRNA |
| Cancer type | Pan-cancer, Solid tumor |
| Content specifications | 18 driver genes and 83 partners |
| Description | The Pillar oncoReveal Fusion LBx Panel is a robust cfRNA liquid biopsy NGS assay that interrogates fusion transcripts from 18 driver genes with more than 80 partners relevant across multiple solid tumor types. |
| Instruments | MiSeqDx in Research Mode , NextSeq 550Dx in Research Mode , MiSeq i100 System |
| Mechanism of action | Multiplex PCR using tiled amplicon |
| Method | Amplicon sequencing , Targeted RNA sequencing |
| Nucleic acid type | RNA |
| Number of amplicons | Pool 1: 83 amplicons |
| Number of reactions | 24 reactions per kit |
| Specialized sample types | Cell-free RNA |
| Species category | Human |
| Strand specificity | Non-stranded |
| Target insert size | 80 bp |
| Technology | Sequencing |
| Variant class | Gene fusions |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.